Wire Stories
Takeda to Present Rare Bleeding Disorders Research Highlighting Need for Real-World Evidence at NHF Bleeding Disorders Conference 2020
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–#TAKEDA–Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented three abstracts at the 72nd National Hemophilia Foundation’s...